Fesnak, Andrew D.

CRISPR-engineered T cells in patients with refractory cancer

Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., et al. (2020) · Science

CAR-T cell therapy researchCRISPR and Genetic Engineering

Cited by 1,478

Engineered T cells: the promise and challenges of cancer immunotherapy

Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 1,074

Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Abou-el-Enein, M., Elsallab, M., Feldman, S. A., Fesnak, A. D., Heslop, H. E., Marks, P., Till, B. G., Bauer, G., & Savoldo, B. (2021) · Blood Cancer Discovery

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 321

The challenge of variability in chimeric antigen receptor T cell manufacturing

Fesnak, A. D. (2020) · Regenerative Engineering and Translational Medicine

CAR-T cell therapy researchBlood transfusion and management

Cited by 45

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies

Wang, K., Liu, Y., Li, J., Wang, B., Bishop, R., White, C., Das, A., Levine, A. D., Ho, L., Levine, B. L., et al. (2019) · Cytotherapy

Simulation Techniques and ApplicationsSupply Chain and Inventory Management

Cited by 29

Predictors of manufacturing (MFG) success for chimeric antigen receptor (CAR) T cells in non-Hodgkin lymphoma (NHL)

Davis, M. M., Fesnak, A., Leskowitz, R. M., McKee, J. S., Ohayon, Y., Corl, C. M., Malykhin, A., Fraietta, J. A., Joseph Melenhorst, J., June, C., et al. (2017) · Cytotherapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 11